Dr. Houston Eccleston Holmes III, MD
- Medicare services, 2024
- 46,086
- Medicare patients, 2024
- 506
- Part D claims, 2024
- 753
- Publications
- 7
- Clinical trials
- 10
- Practice address
- 3410 Worth St, Dallas, TX 75246
- Practice phone
- Call (972) 997-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Texas Oncology PA
Dallas, Texas
Find Dr. Holmes' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Houston Eccleston Holmes III is a hematologist and oncologist in Dallas, Texas
Dr. Holmes practices at Texas Oncology PA in Dallas, Texas.
Dr. Holmes' NPI, 1053354464, was assigned on June 14, 2006. Dr. Holmes graduated from UT Southwestern Medical Center in 1990. Dr. Holmes holds Texas license H9998.
- NPI
- 1053354464NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8820987159
- NPI enumeration date
- June 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (972) 997-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Houston Eccleston Holmes III practices at Texas Oncology PA in Dallas, Texas
Dr. Holmes' primary practice is Texas Oncology PA, at 3410 Worth St, Dallas, TX 75246 in Dallas County. The practice phone is (972) 997-8000.
- Texas Oncology PA3410 Worth St, Dallas, TX 75246 · Dallas CountyPhone(972) 997-8000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Houston Eccleston Holmes III is affiliated with 3 sites of care and 1 medical group
Dr. Holmes' primary practice is Texas Oncology PA in Dallas, Texas. Dr. Holmes is also affiliated with Baylor University Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. Holmes to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Houston Eccleston Holmes III's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holmes practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Texas Oncology PA | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Houston Eccleston Holmes III is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Holmes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Holmes is board certified in hematology by the American Board of Internal Medicine. Dr. Holmes is licensed in Texas.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Holmes treats.
Hematologists and oncologists near Dr. Holmes
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Houston Eccleston Holmes III billed Medicare for 46,086 services in 2024
CMS data shows 46,086 Medicare services from Dr. Holmes across 55 procedure codes in 2024, for 506 Medicare patients. Medicare paid $541,480 for them.
Dr. Holmes' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 29,0172024: 36,90927%
- Other services
- 2023: 4,1402024: 4,0941%
- Lab and pathology
- 2023: 3,3002024: 2,70218%
- Tests and treatments
- 2023: 8372024: 93712%
- Office and hospital visits
- 2023: 8472024: 69019%
- Surgery
- 2023: 8592024: 67621%
- Imaging
- 2023: 912024: 7814%
Where Dr. Holmes' Medicare services took place, 2024
- In an office45,968100%
- In a facility1180%
Dr. Holmes compared with the Texas median for hematologists and oncologists, 2024
- Dr. Holmes
- Texas median
- Medicare services
- 46,086vs 1,16239.7 times
- Medicare patients
- 506vs 2512.0 times
- Part D claims
- 638vs 48930% above
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Holmes' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Holmes?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Holmes and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Houston Eccleston Holmes III treated 506 Medicare patients in 2024, average age 75
CMS counts 506 Medicare patients who saw Dr. Holmes in 2024. The largest group is 75 to 84, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Holmes' median patient age at 69, with 50% women.
Dr. Holmes' Medicare patients by age, 2024
Dr. Holmes' Medicare patients by sex, 2024
- Women27554%
- Men23146%
Chronic conditions among Dr. Holmes' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis42%
- Cancer34%
- Chronic kidney disease32%
- Diabetes31%
- Ischemic heart disease29%
- Anxiety21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Holmes' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women50%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Houston Eccleston Holmes III wrote 753 Medicare Part D claims in 2024
In 2024, Dr. Holmes wrote 753 Medicare Part D claims for 86 patients. 50% of them were for generic drugs. CMS names the drug for 638 of them, across 18 drugs with 11 or more claims each, at $5,289,631 in total drug cost. In 2023, CMS named 631 claims across 19 drugs.
Dr. Holmes' Part D claims by kind of drug, 2024
- Generic375 claims50%
- Brand-name378 claims50%
Dr. Holmes' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Holmes' Part D claims, 2024
- Opioids10%72 of 753 claims
- Antibiotics3%24 of 753 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6312024: 6381%
Drugs named by CMS: 18 in 2024, 19 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Houston Eccleston Holmes III scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Holmes for performance year 2024, reported through an alternative payment model (APM). Dr. Holmes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holmes as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Holmes' MIPS scores, performance year 2024
- 85of 100Final score
- 67.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Houston Eccleston Holmes III has 7 publications on record
Dmand AI links 7 papers to Dr. Holmes, published from 2011 to 2022. The most frequent topics are Lymphoma, Mantle-Cell, Antineoplastic Combined Chemotherapy Protocols and Immunotherapy, Adoptive. Dr. Holmes has published most often in J Clin Oncol. Dr. Holmes' most frequent co-authors are Amer M. Beitinjaneh, MD, Andre H. Goy, MD and Frederick Lundry Locke, MD.
Topics Dr. Holmes writes about most
- Lymphoma, Mantle-Cell
- Antineoplastic Combined Chemotherapy Protocols
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
Dr. Holmes' most frequent co-authors
- Amer M. Beitinjaneh, MD2 shared papers
- Andre H. Goy, MD2 shared papers
- Frederick Lundry Locke, MD2 shared papers
Recent publications by Dr. Holmes
N Engl J Med
See who Dr. Holmes researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Holmes works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Houston Eccleston Holmes III has worked on 10 clinical trials
Dmand AI links Dr. Holmes to 10 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell and Lymphoma, Non-Hodgkin. Celgene sponsors the most, 2.
Clinical trials with Dr. Holmes by phase
- 2Phase 1: 2 trials
- 2Phase 1/2: 2 trials
- 1Phase 2: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Holmes' trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Leukemia, B-Cell
- Brain Neoplasms
Investigators on the most trials with Dr. Holmes
- Lowell L. Hart, MD2 shared trials
- Marilyn Cynthia Raymond, MD2 shared trials
- Stephen J. Schuster, MD2 shared trials
Recent clinical trials with Dr. Holmes
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) (opens in a new tab)
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (opens in a new tab)
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Houston Eccleston Holmes III received $267,695 in industry payments from 2016 to 2025
CMS Open Payments shows 428 general payments to Dr. Holmes from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Kite Pharma, Inc. paid the most, $132,462. It also lists 8 research payments totaling $4,384 from 2019 to 2025.
General payments to Dr. Holmes by program year, 2016 to 2025
General payments to Dr. Holmes by kind, 2016 to 2025
- Speaker and faculty fees$126,38647%
- Consulting fees$94,35735%
- Travel and lodging$22,0098%
- Honoraria$15,5036%
- Other$9,4404%
Companies that paid Dr. Holmes the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Houston Eccleston Holmes III has 4 awards and honors on record
Dmand AI lists 4 awards for Dr. Holmes, most recently ACP Fellow in 2012.
Awards and honors for Dr. Holmes
- 2012
- ACP Fellow
- 2000
- CMS Stage 1 2012
- Undated
- Checkbook Top Doc
- Super Doc
Source: Dmand AI Professional Profile Data
Dr. Houston Eccleston Holmes III graduated from UT Southwestern Medical Center
Dr. Holmes graduated from UT Southwestern Medical Center in 1990. Dr. Holmes is a member of AACR, ACP, ASCO, ASH and Texas Medical Association.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Houston Eccleston Holmes III accepts plans from 22 insurance carriers
Dr. Holmes is in network with 22 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Cigna
- Elevance
- HCSC
- Alliant Health Plans
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- +14 more carriersWith a free account
Plan types Dr. Holmes accepts, by number of carriers
- PPO13
- HMO12
- Medicare8
- EPO4
- POS4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Houston Eccleston Holmes III's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Houston Eccleston Holmes III
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Houston Eccleston Holmes III's NPI number?
Dr. Houston Eccleston Holmes III's NPI number is 1053354464. It was assigned on June 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Houston Eccleston Holmes III?
Dr. Houston Eccleston Holmes III is a hematologist and oncologist in Dallas, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Houston Eccleston Holmes III practice?
Dr. Holmes practices at 3410 Worth St, Dallas, TX 75246. Dr. Holmes' primary practice is Texas Oncology PA in Dallas, Texas. Dmand AI also links Dr. Holmes to 1 group practice or clinic.
What is Dr. Houston Eccleston Holmes III's office phone number?
The practice phone on file for Dr. Holmes is (972) 997-8000.
What is Dr. Houston Eccleston Holmes III's medical license number?
Dr. Holmes holds Texas license H9998.
Which hospitals is Dr. Houston Eccleston Holmes III affiliated with?
Dr. Holmes is affiliated with Baylor University Medical Center.
What medical group is Dr. Houston Eccleston Holmes III part of?
Dr. Holmes is linked to Texas Oncology.
Does Dr. Houston Eccleston Holmes III accept Medicare?
Yes. CMS data shows Dr. Holmes billed Medicare for 46,086 services in 2024, and Dr. Holmes accepts Medicare assignment.
Does Dr. Houston Eccleston Holmes III offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Holmes as offering telehealth services.
What is Dr. Houston Eccleston Holmes III's MIPS score?
Dr. Holmes' MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Houston Eccleston Holmes III see?
CMS counts 506 Medicare patients who saw Dr. Holmes in 2024, with an average age of 75.
Is Dr. Houston Eccleston Holmes III board certified?
Yes. Dr. Holmes is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Houston Eccleston Holmes III bill to Medicare?
In 2024, Dr. Holmes' most billed Medicare services were injected or infused drug (J1453), injected or infused drug (J9263) and injected or infused drug (J9267).
Where did Dr. Houston Eccleston Holmes III go to medical school?
Dr. Holmes graduated from UT Southwestern Medical Center in 1990.
What drugs does Dr. Houston Eccleston Holmes III prescribe most?
In 2024 Medicare Part D data, Dr. Holmes' most prescribed drugs by claims were Brukinsa, Revlimid and Acyclovir.
Has Dr. Houston Eccleston Holmes III received payments from drug or device companies?
CMS Open Payments shows $267,695 in general payments to Dr. Holmes from 52 companies from 2016 to 2025. The largest total came from Kite Pharma, Inc.
How long has Dr. Houston Eccleston Holmes III been practicing?
Dr. Holmes graduated from medical school in 1990, 36 years ago.
Does Dr. Houston Eccleston Holmes III do research?
Dmand AI links 7 publications to Dr. Holmes, published from 2011 to 2022. Dr. Holmes has worked on 10 clinical trials.
Who does Dr. Houston Eccleston Holmes III publish with?
Dr. Holmes' most frequent co-authors are Amer M. Beitinjaneh, MD (2 shared papers), Andre H. Goy, MD (2 shared papers) and Frederick Lundry Locke, MD (2 shared papers).
What insurance does Dr. Houston Eccleston Holmes III accept?
Dr. Holmes is in network with 22 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card